Position in IDXX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,573,853
+$1,277,417 QoQ
Shares Held
2,801
+290.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026GSA CAPITAL PARTNERS LLP holds $12,036,211 across 17 Diagnostics & Research names. IDXX ranks #2 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
13,542 | $2,567,563 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
This page
|
2,801 | $1,573,853 | |
| 3 | MYGN |
Myriad Genetics Inc
|
339,902 | $1,529,559 | |
| 4 | A |
Agilent Technologies, Inc.
|
8,721 | $994,019 | |
| 5 | XGN |
Exagen Inc.
|
253,005 | $759,015 | |
| 6 | OPK |
Opko Health, Inc.
|
663,704 | $756,622 | |
| 7 | BDSX |
Biodesix Inc
|
39,406 | $571,387 | |
| 8 | PSNL |
Personalis, Inc.
|
82,175 | $523,454 |
All Filings in IDXX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,573,853 | 2,801 | Shares | Sole | 2026-05-08 | |
| 2024-12-31 | $296,436 | 717 | Shares | Sole | 2025-02-07 | |
| 2024-03-31 | $1,472,389 | 2,727 | Shares | Sole | 2024-05-03 | |
| 2023-06-30 | $2,934,529 | 5,843 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $321,880 | 789 | Shares | Sole | 2023-02-13 | |
| 2022-06-30 | $269,009 | 767 | Shares | Sole | 2022-08-09 | |
| 2021-09-30 | $292,914 | 471 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $361,110 | 738 | Shares | Sole | 2021-05-10 | |
| 2020-09-30 | $509,077 | 1,295 | Shares | Sole | 2020-11-06 | |
| No filing history on record for this holder in this stock. | ||||||